Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations

Cancer-associated fibroblasts (CAF) are a poorly characterized cell population in the context of liver cancer. Our study investigates CAF functions in intrahepatic cholangiocarcinoma (ICC), a highly desmoplastic liver tumor. Genetic tracing, single-cell RNA sequencing, and ligand-receptor analyses u...

Full description

Saved in:
Bibliographic Details
Published inCancer cell Vol. 39; no. 6; pp. 866 - 882.e11
Main Authors Affo, Silvia, Nair, Ajay, Brundu, Francesco, Ravichandra, Aashreya, Bhattacharjee, Sonakshi, Matsuda, Michitaka, Chin, LiKang, Filliol, Aveline, Wen, Wen, Song, Xinhua, Decker, Aubrianna, Worley, Jeremy, Caviglia, Jorge Matias, Yu, Lexing, Yin, Deqi, Saito, Yoshinobu, Savage, Thomas, Wells, Rebecca G., Mack, Matthias, Zender, Lars, Arpaia, Nicholas, Remotti, Helen E., Rabadan, Raul, Sims, Peter, Leblond, Anne-Laure, Weber, Achim, Riener, Marc-Oliver, Stockwell, Brent R., Gaublomme, Jellert, Llovet, Josep M., Kalluri, Raghu, Michalopoulos, George K., Seki, Ekihiro, Sia, Daniela, Chen, Xin, Califano, Andrea, Schwabe, Robert F.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 14.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cancer-associated fibroblasts (CAF) are a poorly characterized cell population in the context of liver cancer. Our study investigates CAF functions in intrahepatic cholangiocarcinoma (ICC), a highly desmoplastic liver tumor. Genetic tracing, single-cell RNA sequencing, and ligand-receptor analyses uncovered hepatic stellate cells (HSC) as the main source of CAF and HSC-derived CAF as the dominant population interacting with tumor cells. In mice, CAF promotes ICC progression, as revealed by HSC-selective CAF depletion. In patients, a high panCAF signature is associated with decreased survival and increased recurrence. Single-cell RNA sequencing segregates CAF into inflammatory and growth factor-enriched (iCAF) and myofibroblastic (myCAF) subpopulations, displaying distinct ligand-receptor interactions. myCAF-expressed hyaluronan synthase 2, but not type I collagen, promotes ICC. iCAF-expressed hepatocyte growth factor enhances ICC growth via tumor-expressed MET, thus directly linking CAF to tumor cells. In summary, our data demonstrate promotion of desmoplastic ICC growth by therapeutically targetable CAF subtype-specific mediators, but not by type I collagen. [Display omitted] •The majority of CAF in ICC are derived from hepatic stellate cells•Inflammatory CAF promote ICC through HGF and its receptor MET•myCAF promote ICC through Has2/hyaluronic acid•CAF-derived type I collagen contributes to stiffness but does not promote ICC growth Intrahepatic cholangiocarcinoma (ICC) is an extraordinarily stiff liver tumor due to abundant scar-forming cancer-associated fibroblasts (CAF). Here, Affo et al. determine the origin and functions of CAF, and uncover distinct CAF subsets, promoting ICC growth via different therapeutically targetable mediators. Thus, CAF and their mediators may serve as therapeutic targets for ICC.
AbstractList Cancer-associated fibroblasts (CAF) are a poorly characterized cell population in the context of liver cancer. Our study investigates CAF functions in intrahepatic cholangiocarcinoma (ICC), a highly desmoplastic liver tumor. Genetic tracing, single-cell RNA sequencing, and ligand-receptor analyses uncovered hepatic stellate cells (HSC) as the main source of CAF and HSC-derived CAF as the dominant population interacting with tumor cells. In mice, CAF promotes ICC progression, as revealed by HSC-selective CAF depletion. In patients, a high panCAF signature is associated with decreased survival and increased recurrence. Single-cell RNA sequencing segregates CAF into inflammatory and growth factor-enriched (iCAF) and myofibroblastic (myCAF) subpopulations, displaying distinct ligand-receptor interactions. myCAF-expressed hyaluronan synthase 2, but not type I collagen, promotes ICC. iCAF-expressed hepatocyte growth factor enhances ICC growth via tumor-expressed MET, thus directly linking CAF to tumor cells. In summary, our data demonstrate promotion of desmoplastic ICC growth by therapeutically targetable CAF subtype-specific mediators, but not by type I collagen.Cancer-associated fibroblasts (CAF) are a poorly characterized cell population in the context of liver cancer. Our study investigates CAF functions in intrahepatic cholangiocarcinoma (ICC), a highly desmoplastic liver tumor. Genetic tracing, single-cell RNA sequencing, and ligand-receptor analyses uncovered hepatic stellate cells (HSC) as the main source of CAF and HSC-derived CAF as the dominant population interacting with tumor cells. In mice, CAF promotes ICC progression, as revealed by HSC-selective CAF depletion. In patients, a high panCAF signature is associated with decreased survival and increased recurrence. Single-cell RNA sequencing segregates CAF into inflammatory and growth factor-enriched (iCAF) and myofibroblastic (myCAF) subpopulations, displaying distinct ligand-receptor interactions. myCAF-expressed hyaluronan synthase 2, but not type I collagen, promotes ICC. iCAF-expressed hepatocyte growth factor enhances ICC growth via tumor-expressed MET, thus directly linking CAF to tumor cells. In summary, our data demonstrate promotion of desmoplastic ICC growth by therapeutically targetable CAF subtype-specific mediators, but not by type I collagen.
Cancer-associated fibroblasts (CAF) are a poorly characterized cell population in the context of liver cancer. Our study investigates CAF functions in intrahepatic cholangiocarcinoma (ICC), a highly desmoplastic liver tumor. Genetic tracing, single-cell RNA sequencing, and ligand-receptor analyses uncovered hepatic stellate cells (HSC) as the main source of CAF and HSC-derived CAF as the dominant population interacting with tumor cells. In mice, CAF promotes ICC progression, as revealed by HSC-selective CAF depletion. In patients, a high panCAF signature is associated with decreased survival and increased recurrence. Single-cell RNA sequencing segregates CAF into inflammatory and growth factor-enriched (iCAF) and myofibroblastic (myCAF) subpopulations, displaying distinct ligand-receptor interactions. myCAF-expressed hyaluronan synthase 2, but not type I collagen, promotes ICC. iCAF-expressed hepatocyte growth factor enhances ICC growth via tumor-expressed MET, thus directly linking CAF to tumor cells. In summary, our data demonstrate promotion of desmoplastic ICC growth by therapeutically targetable CAF subtype-specific mediators, but not by type I collagen. [Display omitted] •The majority of CAF in ICC are derived from hepatic stellate cells•Inflammatory CAF promote ICC through HGF and its receptor MET•myCAF promote ICC through Has2/hyaluronic acid•CAF-derived type I collagen contributes to stiffness but does not promote ICC growth Intrahepatic cholangiocarcinoma (ICC) is an extraordinarily stiff liver tumor due to abundant scar-forming cancer-associated fibroblasts (CAF). Here, Affo et al. determine the origin and functions of CAF, and uncover distinct CAF subsets, promoting ICC growth via different therapeutically targetable mediators. Thus, CAF and their mediators may serve as therapeutic targets for ICC.
Cancer-associated fibroblasts (CAF) are a poorly characterized cell population in the context of liver cancer. Our study investigates CAF functions in intrahepatic cholangiocarcinoma (ICC), a highly desmoplastic liver tumor. Genetic tracing, single-cell RNA sequencing, and ligand-receptor analyses uncovered hepatic stellate cells (HSC) as the main source of CAF and HSC-derived CAF as the dominant population interacting with tumor cells. In mice, CAF promotes ICC progression, as revealed by HSC-selective CAF depletion. In patients, a high panCAF signature is associated with decreased survival and increased recurrence. Single-cell RNA sequencing segregates CAF into inflammatory and growth factor-enriched (iCAF) and myofibroblastic (myCAF) subpopulations, displaying distinct ligand-receptor interactions. myCAF-expressed hyaluronan synthase 2, but not type I collagen, promotes ICC. iCAF-expressed hepatocyte growth factor enhances ICC growth via tumor-expressed MET, thus directly linking CAF to tumor cells. In summary, our data demonstrate promotion of desmoplastic ICC growth by therapeutically targetable CAF subtype-specific mediators, but not by type I collagen.
Cancer-associated fibroblasts (CAF) are a poorly characterized cell population in the context of liver cancer. Our study investigates CAF functions in intrahepatic cholangiocarcinoma (ICC), a highly desmoplastic liver tumor. Genetic tracing, single-cell RNA-sequencing and ligand-receptor analyses uncovered hepatic stellate cells (HSC) as the main source of CAF, and HSC-derived CAF as dominant population interacting with tumor cells. In mice, CAF promotes ICC progression, as revealed by HSC-selective CAF depletion. In patients, a high panCAF signature is associated with decreased survival and increased recurrence. Single-cell RNA-sequencing segregates CAF into inflammatory and growth factor-enriched (iCAF) and myofibroblastic (myCAF) subpopulations, displaying distinct ligand-receptor interactions. myCAF-expressed hyaluronan synthase 2 but not type I collagen, promotes ICC. iCAF-expressed HGF enhances ICC growth via tumor-expressed MET, thus directly linking CAF to tumor cells. In summary, our data demonstrate promotion of desmoplastic ICC growth by therapeutically targetable CAF subtype-specific mediators, but not by type I collagen. Intrahepatic cholangiocarcinoma (ICC) is an extraordinarily stiff liver tumor due to abundant scar-forming cancer-associated fibroblasts (CAF). Here, Affo et al. determine origin and functions of CAF, and uncover distinct CAF subsets, promoting ICC growth via different therapeutically targetable mediators. Thus, CAF and their mediators may serve as therapeutic targets for ICC.
Author Wen, Wen
Riener, Marc-Oliver
Remotti, Helen E.
Ravichandra, Aashreya
Schwabe, Robert F.
Sims, Peter
Worley, Jeremy
Kalluri, Raghu
Sia, Daniela
Califano, Andrea
Gaublomme, Jellert
Seki, Ekihiro
Wells, Rebecca G.
Nair, Ajay
Decker, Aubrianna
Matsuda, Michitaka
Arpaia, Nicholas
Affo, Silvia
Caviglia, Jorge Matias
Yin, Deqi
Zender, Lars
Stockwell, Brent R.
Savage, Thomas
Chin, LiKang
Llovet, Josep M.
Yu, Lexing
Chen, Xin
Bhattacharjee, Sonakshi
Brundu, Francesco
Mack, Matthias
Weber, Achim
Song, Xinhua
Michalopoulos, George K.
Filliol, Aveline
Leblond, Anne-Laure
Rabadan, Raul
Saito, Yoshinobu
AuthorAffiliation 1 Department of Medicine, Columbia University, New York, 10032, NY, USA
22 Department of Biochemistry & Molecular Biophysics, Columbia University, New York, 10032, NY, USA
8 Department of Nephrology, University Hospital Regensburg, 93053, Regensburg, Germany
11 iFIT Cluster of Excellence EXC 2180, University of Tuebingen, 72076, Tuebingen, Germany
13 Department of Pathology & Cell Biology, Columbia University, New York, 10032, NY, USA
20 Department of Pathology, University of Pittsburgh, Pittsburgh, 15213, PA, USA
19 Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
5 Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, 94158, CA, USA
12 Herbert Irving Comprehensive Cancer Center, Columbia University, New York, 10032, NY, USA
21 Department of Biomedical Informatics, Columbia University, New York, 10032, NY, USA
18 Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Med
AuthorAffiliation_xml – name: 3 Department of Medicine, Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, 90024, CA, USA
– name: 21 Department of Biomedical Informatics, Columbia University, New York, 10032, NY, USA
– name: 22 Department of Biochemistry & Molecular Biophysics, Columbia University, New York, 10032, NY, USA
– name: 19 Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
– name: 15 Department for Pathology and Molecular Pathology, Zürich University Hospital, 8091, Zürich, Switzerland
– name: 13 Department of Pathology & Cell Biology, Columbia University, New York, 10032, NY, USA
– name: 18 Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, 10029, NY, USA
– name: 7 Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, 10032, NY, USA
– name: 23 Institute of Human Nutrition, Columbia University, New York, 10032, NY, USA
– name: 2 Department of Systems Biology, Columbia University Irving Medical Center, New York, 10032, NY, USA
– name: 1 Department of Medicine, Columbia University, New York, 10032, NY, USA
– name: 14 Department of Systems Biology, Columbia University, New York, 10032, NY, USA
– name: 20 Department of Pathology, University of Pittsburgh, Pittsburgh, 15213, PA, USA
– name: 17 Liver Cancer Translational Research Laboratory, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, 08036, Barcelona, Spain
– name: 11 iFIT Cluster of Excellence EXC 2180, University of Tuebingen, 72076, Tuebingen, Germany
– name: 12 Herbert Irving Comprehensive Cancer Center, Columbia University, New York, 10032, NY, USA
– name: 6 Department of Biological Sciences, Columbia University, New York, 10027, NY, USA
– name: 16 Department of Chemistry, Columbia University, New York, 10027, NY, USA
– name: 4 Department of Medicine, Penn Physical Sciences in Oncology Center PSOC@Penn, University of Pennsylvania, Philadelphia, PA 19104, USA
– name: 5 Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, 94158, CA, USA
– name: 8 Department of Nephrology, University Hospital Regensburg, 93053, Regensburg, Germany
– name: 24 Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
– name: 10 German Cancer Research Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany
– name: 9 Department of Medical Oncology and Pneumology, University Hospital Tuebingen, 72076, Tuebingen, Germany
Author_xml – sequence: 1
  givenname: Silvia
  surname: Affo
  fullname: Affo, Silvia
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 2
  givenname: Ajay
  orcidid: 0000-0003-4521-5614
  surname: Nair
  fullname: Nair, Ajay
  organization: Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA
– sequence: 3
  givenname: Francesco
  orcidid: 0000-0003-2133-1426
  surname: Brundu
  fullname: Brundu, Francesco
  organization: Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA
– sequence: 4
  givenname: Aashreya
  orcidid: 0000-0001-5785-8524
  surname: Ravichandra
  fullname: Ravichandra, Aashreya
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 5
  givenname: Sonakshi
  surname: Bhattacharjee
  fullname: Bhattacharjee, Sonakshi
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 6
  givenname: Michitaka
  surname: Matsuda
  fullname: Matsuda, Michitaka
  organization: Department of Medicine, Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA 90024, USA
– sequence: 7
  givenname: LiKang
  surname: Chin
  fullname: Chin, LiKang
  organization: Department of Medicine, Penn Physical Sciences in Oncology Center PSOC@Penn, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 8
  givenname: Aveline
  surname: Filliol
  fullname: Filliol, Aveline
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 9
  givenname: Wen
  orcidid: 0000-0002-7835-922X
  surname: Wen
  fullname: Wen, Wen
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 10
  givenname: Xinhua
  surname: Song
  fullname: Song, Xinhua
  organization: Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, CA 94158, USA
– sequence: 11
  givenname: Aubrianna
  orcidid: 0000-0002-0646-1815
  surname: Decker
  fullname: Decker, Aubrianna
  organization: Department of Biological Sciences, Columbia University, New York, NY 10027, USA
– sequence: 12
  givenname: Jeremy
  surname: Worley
  fullname: Worley, Jeremy
  organization: Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA
– sequence: 13
  givenname: Jorge Matias
  surname: Caviglia
  fullname: Caviglia, Jorge Matias
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 14
  givenname: Lexing
  surname: Yu
  fullname: Yu, Lexing
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 15
  givenname: Deqi
  orcidid: 0000-0002-0022-3269
  surname: Yin
  fullname: Yin, Deqi
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 16
  givenname: Yoshinobu
  orcidid: 0000-0002-0624-0449
  surname: Saito
  fullname: Saito, Yoshinobu
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 17
  givenname: Thomas
  orcidid: 0000-0002-6618-2973
  surname: Savage
  fullname: Savage, Thomas
  organization: Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
– sequence: 18
  givenname: Rebecca G.
  orcidid: 0000-0002-6988-4102
  surname: Wells
  fullname: Wells, Rebecca G.
  organization: Department of Medicine, Penn Physical Sciences in Oncology Center PSOC@Penn, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 19
  givenname: Matthias
  surname: Mack
  fullname: Mack, Matthias
  organization: Department of Nephrology, University Hospital Regensburg, 93053 Regensburg, Germany
– sequence: 20
  givenname: Lars
  surname: Zender
  fullname: Zender, Lars
  organization: Department of Medical Oncology and Pneumology, University Hospital Tuebingen, 72076 Tuebingen, Germany
– sequence: 21
  givenname: Nicholas
  orcidid: 0000-0002-0657-0528
  surname: Arpaia
  fullname: Arpaia, Nicholas
  organization: Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
– sequence: 22
  givenname: Helen E.
  surname: Remotti
  fullname: Remotti, Helen E.
  organization: Department of Pathology & Cell Biology, Columbia University, New York, NY 10032, USA
– sequence: 23
  givenname: Raul
  surname: Rabadan
  fullname: Rabadan, Raul
  organization: Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA
– sequence: 24
  givenname: Peter
  surname: Sims
  fullname: Sims, Peter
  organization: Department of Systems Biology, Columbia University, New York, NY 10032, USA
– sequence: 25
  givenname: Anne-Laure
  surname: Leblond
  fullname: Leblond, Anne-Laure
  organization: Department for Pathology and Molecular Pathology, Zürich University Hospital, 8091 Zürich, Switzerland
– sequence: 26
  givenname: Achim
  orcidid: 0000-0003-0073-3637
  surname: Weber
  fullname: Weber, Achim
  organization: Department for Pathology and Molecular Pathology, Zürich University Hospital, 8091 Zürich, Switzerland
– sequence: 27
  givenname: Marc-Oliver
  surname: Riener
  fullname: Riener, Marc-Oliver
  organization: Department for Pathology and Molecular Pathology, Zürich University Hospital, 8091 Zürich, Switzerland
– sequence: 28
  givenname: Brent R.
  surname: Stockwell
  fullname: Stockwell, Brent R.
  organization: Department of Biological Sciences, Columbia University, New York, NY 10027, USA
– sequence: 29
  givenname: Jellert
  surname: Gaublomme
  fullname: Gaublomme, Jellert
  organization: Department of Biological Sciences, Columbia University, New York, NY 10027, USA
– sequence: 30
  givenname: Josep M.
  surname: Llovet
  fullname: Llovet, Josep M.
  organization: Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, 08036 Barcelona, Spain
– sequence: 31
  givenname: Raghu
  surname: Kalluri
  fullname: Kalluri, Raghu
  organization: Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 32
  givenname: George K.
  orcidid: 0000-0001-9922-6920
  surname: Michalopoulos
  fullname: Michalopoulos, George K.
  organization: Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15213, USA
– sequence: 33
  givenname: Ekihiro
  orcidid: 0000-0002-9472-6085
  surname: Seki
  fullname: Seki, Ekihiro
  organization: Department of Medicine, Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA 90024, USA
– sequence: 34
  givenname: Daniela
  surname: Sia
  fullname: Sia, Daniela
  organization: Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
– sequence: 35
  givenname: Xin
  surname: Chen
  fullname: Chen, Xin
  organization: Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, CA 94158, USA
– sequence: 36
  givenname: Andrea
  orcidid: 0000-0003-4742-3679
  surname: Califano
  fullname: Califano, Andrea
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
– sequence: 37
  givenname: Robert F.
  surname: Schwabe
  fullname: Schwabe, Robert F.
  email: rfs2102@cumc.columbia.edu
  organization: Department of Medicine, Columbia University, New York, NY 10032, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33930309$$D View this record in MEDLINE/PubMed
BookMark eNpVkVtr3DAQhUVJaS7tLygUP-bFri62VnpIIIQ2LQTah7wWMZLGu1psaSPZW_Lv682N9GkG5swZ5nyn5CimiIR8ZrRhlMmv28Y5HIaGU84aKhrK-DtywtRK1UIqebT0nehqyag6JqelbOmyxVb6AzkWQgsqqD4hf37nNKYppFilvnKbNEBch-QguxDTCNU6p7_TprIPlQ97zAUrB9FhrqGU5AJM6Ks-2JzsAGWqymx3aTcPcLAsH8n7HoaCn57rGbn7_u3u-kd9--vm5_XVbY2tYFPt21ZR1TlQSlgrJXoFXHsJzlNNW94Co3alFXLeS0RsV9ZC63RvlbK9F2fk8sl2N9sRvcM4ZRjMLocR8oNJEMz_kxg2Zp32RvGWcdEtBufPBjndz1gmM4ZyCBciprkY3nGqpNBML9Ivb2-9HnmJdBFcPAlweXgfMJviAi6R-ZDRTcanYBg1B4Rmax4RmgNCQ4VZEIp_1naU8g
ContentType Journal Article
Copyright 2021 Elsevier Inc.
Copyright © 2021 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2021 Elsevier Inc.
– notice: Copyright © 2021 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.ccell.2021.03.012
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1878-3686
EndPage 882.e11
ExternalDocumentID PMC8241235
33930309
S1535610821001707
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: U01 CA217858
– fundername: NCI NIH HHS
  grantid: R35 CA197745
– fundername: NCI NIH HHS
  grantid: U54 CA193417
– fundername: NIDDK NIH HHS
  grantid: R03 DK101863
– fundername: NCI NIH HHS
  grantid: R35 CA209896
– fundername: NIDDK NIH HHS
  grantid: R01 DK085252
– fundername: NIH HHS
  grantid: S10 OD021764
– fundername: NCI NIH HHS
  grantid: R01 CA190606
– fundername: NINDS NIH HHS
  grantid: R61 NS109407
– fundername: NIH HHS
  grantid: S10 OD012351
GroupedDBID ---
--K
0R~
1~5
29B
2WC
4.4
457
4G.
53G
5GY
62-
6J9
7-5
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAKRW
AAKUH
AALRI
AAUCE
AAVLU
AAXUO
ABJNI
ABMAC
ABMWF
ABVKL
ACGFO
ACGFS
ADBBV
ADEZE
ADJPV
AEFWE
AENEX
AEXQZ
AFTJW
AGKMS
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
CS3
DIK
DU5
E3Z
EBS
F5P
FCP
FDB
FEDTE
FIRID
HVGLF
IH2
IHE
IXB
J1W
JIG
M3Z
M41
O-L
O9-
OK1
P2P
RCE
ROL
RPZ
SES
SSZ
TR2
UDS
WQ6
ZA5
AAFWJ
AAMRU
AAYWO
ABDGV
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AGCQF
AIGII
AKAPO
AKBMS
AKRWK
AKYEP
APXCP
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-e431t-d448085ca883bb66ed8a29d6acd090424a10b798e22f6eee47bba4c9fb88bfd3
IEDL.DBID IXB
ISSN 1535-6108
1878-3686
IngestDate Thu Aug 21 13:45:51 EDT 2025
Tue Aug 05 10:00:15 EDT 2025
Mon Jul 21 06:00:28 EDT 2025
Fri Feb 23 02:43:40 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords single cell
immune
mechanosensitive
CellPhoneDB
HGF
YAP
KRAS
tumor microenvironment
stiffness
cholangiocarcinoma
Language English
License Copyright © 2021 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-e431t-d448085ca883bb66ed8a29d6acd090424a10b798e22f6eee47bba4c9fb88bfd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceptualization, R.F.S and S.A.; Methodology, R.F.S., S.A., X.C., R.G.W., A.N., F.B., D.S.; Experimentation, S.A., A.N, F.B., A.R., S.B., T.S., M.M., L.C., A.F., W.W., Y.S., J.W., D.Y., X.S., A.D., J.M.C., L.Z., H.E.R., A.L.L., D.S.; Writing, R.F.S and S.A.; Funding Acquisition, R.F.S., X.C. and S.A.; Resources, R.F.S., N.A., A.M., M.O.R., B.R.S., J.G., G.K.M., L.S., J.M.L., D.S., E.S., R.R., P.S., X.C., and A.C.; Supervision, R.F.S.
AUTHOR CONTRIBUTIONS
ORCID 0000-0002-0657-0528
0000-0003-4521-5614
0000-0002-9472-6085
0000-0003-4742-3679
0000-0002-6988-4102
0000-0002-0624-0449
0000-0002-0022-3269
0000-0003-0073-3637
0000-0003-2133-1426
0000-0002-6618-2973
0000-0002-7835-922X
0000-0001-5785-8524
0000-0001-9922-6920
0000-0002-0646-1815
OpenAccessLink http://www.cell.com/article/S1535610821001707/pdf
PMID 33930309
PQID 2520863919
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8241235
proquest_miscellaneous_2520863919
pubmed_primary_33930309
elsevier_sciencedirect_doi_10_1016_j_ccell_2021_03_012
PublicationCentury 2000
PublicationDate 2021-06-14
PublicationDateYYYYMMDD 2021-06-14
PublicationDate_xml – month: 06
  year: 2021
  text: 2021-06-14
  day: 14
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer cell
PublicationTitleAlternate Cancer Cell
PublicationYear 2021
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Reich, Liefeld, Gould, Lerner, Tamayo, Mesirov (bib54) 2006; 38
Banales, Marin, Lamarca, Rodrigues, Khan, Roberts, Cardinale, Carpino, Andersen, Braconi (bib4) 2020; 17
Rhim, Oberstein, Thomas, Mirek, Palermo, Sastra, Dekleva, Saunders, Becerra, Tattersall (bib56) 2014; 25
Liotta (bib34) 1986; 46
Ohlund, Handly-Santana, Biffi, Elyada, Almeida, Ponz-Sarvise, Corbo, Oni, Hearn, Lee (bib47) 2017; 214
Hosein, Huang, Wang, Parmar, Du, Huang, Maitra, Olson, Verma, Brekken (bib27) 2019; 5
Marti, Stein, Blumer, Abraham, Dill, Pikiolek, Orsini, Jurisic, Megel, Makowska (bib37) 2015; 62
Vento-Tormo, Efremova, Botting, Turco, Vento-Tormo, Meyer, Park, Stephenson, Polanski, Goncalves (bib70) 2018; 563
Friedman, Levi-Galibov, David, Bornstein, Giladi, Dadiani, Mayo, Halperin, Pevsner-Fischer, Lavon (bib25) 2020; 1
Mederacke, Dapito, Affo, Uchinami, Schwabe (bib42) 2015; 10
Friedman (bib24) 2008; 88
Riener, Vogetseder, Pestalozzi, Clavien, Probst-Hensch, Kristiansen, Jochum (bib57) 2010; 41
Egeblad, Rasch, Weaver (bib19) 2010; 22
Seehawer, Heinzmann, D'Artista, Harbig, Roux, Hoenicke, Dang, Klotz, Robinson, Dore (bib62) 2018; 562
Clements, Eliahoo, Kim, Taylor-Robinson, Khan (bib15) 2020; 72
Senoo, Mezaki, Fujiwara (bib63) 2017; 92
Catenacci, Junttila, Karrison, Bahary, Horiba, Nattam, Marsh, Wallace, Kozloff, Rajdev (bib11) 2015; 33
Sia, Hoshida, Villanueva, Roayaie, Ferrer, Tabak, Peix, Sole, Tovar, Alsinet (bib64) 2013; 144
Chowdhury, Castro, Coker, Hinchliffe, Arpaia, Danino (bib14) 2019; 25
Affo, Yu, Schwabe (bib1) 2017; 12
Chen, Song (bib13) 2019; 18
Huh, Factor, Sanchez, Uchida, Conner, Thorgeirsson (bib28) 2004; 101
Sirica (bib65) 2011; 9
Zhang, Yang, Wan, Wang, Wang, Ge, Liu, Hao, Zhang, Shi (bib74) 2020; 73
Cyphert, Trempus, Garantziotis (bib18) 2015; 2015
Tian, Azpurua, Hine, Vaidya, Myakishev-Rempel, Ablaeva, Mao, Nevo, Gorbunova, Seluanov (bib68) 2013; 499
Rizvi, Khan, Hallemeier, Kelley, Gores (bib59) 2018; 15
Biffi, Tuveson (bib8) 2020; 101
Buchtler, Grill, Hofmarksrichter, Stockert, Schiechl-Brachner, Rodriguez Gomez, Neumayer, Schmidbauer, Talke, Klinkhammer (bib10) 2018; 29
Mertens, Fingas, Christensen, Smoot, Bronk, Werneburg, Gustafson, Dietz, Roberts, Sirica, Gores (bib43) 2013; 73
Ilicic, Kim, Kolodziejczyk, Bagger, McCarthy, Marioni, Teichmann (bib29) 2016; 17
Ramanathan, McDonough, Philip, Hingorani, Lacy, Kortmansky, Thumar, Chiorean, Shields, Behl (bib52) 2019; 37
Lun, Bach, Marioni (bib35) 2016; 17
Pradere, Kluwe, De Minicis, Jiao, Gwak, Dapito, Jang, Guenther, Mederacke, Friedman (bib50) 2013; 58
Blondel, Guillaume, Lambiotte, Lefebvre (bib9) 2008; 6
Barbazan, Matic Vignjevic (bib6) 2019; 56
Levental, Yu, Kass, Lakins, Egeblad, Erler, Fong, Csiszar, Giaccia, Weninger (bib33) 2009; 139
Erez, Truitt, Olson, Arron, Hanahan (bib21) 2010; 17
Mederacke, Hsu, Troeger, Huebener, Mu, Dapito, Pradere, Schwabe (bib41) 2013; 4
Fan, Malato, Calvisi, Naqvi, Razumilava, Ribback, Gores, Dombrowski, Evert, Chen, Willenbring (bib22) 2012; 122
Toole (bib69) 2004; 4
Rousseeuw (bib60) 1987; 20
Kalluri (bib30) 2016; 16
Caviglia, Yan, Jang, Gwak, Affo, Yu, Olinga, Friedman, Chen, Schwabe (bib12) 2018; 67
Wang, Dong, Xu, Song, Zhang, Qiao, Che, Gordan, Hu, Liu (bib71) 2018; 37
Barbie, Tamayo, Boehm, Kim, Moody, Dunn, Schinzel, Sandy, Meylan, Scholl (bib7) 2009; 462
Kononen, Bubendorf, Kallioniemi, Barlund, Schraml, Leighton, Torhorst, Mihatsch, Sauter, Kallioniemi (bib31) 1998; 4
Northey, Przybyla, Weaver (bib46) 2017; 7
Stuart, Butler, Hoffman, Hafemeister, Papalexi, Mauck, Hao, Stoeckius, Smibert, Satija (bib66) 2019; 177
McCarthy, El-Ashry, Turley (bib39) 2018; 6
Matsumoto, Li, Jakuba, Sugiyama, Sayo, Okuno, Dealy, Toole, Takeda, Yamaguchi, Kosher (bib38) 2009; 136
Bankhead, Loughrey, Fernandez, Dombrowski, McArt, Dunne, McQuaid, Gray, Murray, Coleman (bib5) 2017; 7
Krempen, Grotkopp, Hall, Bache, Gillan, Rippe, Brenner, Breindl (bib32) 1999; 8
Aparicio, Bordyuh, Blumberg, Rabadan (bib3) 2020; 1
Comoglio, Trusolino, Boccaccio (bib16) 2018; 18
Mu, Pradere, Affo, Dapito, Friedman, Lefkovitch, Schwabe (bib45) 2016; 150
Provenzano, Cuevas, Chang, Goel, Von Hoff, Hingorani (bib51) 2012; 21
Costa, Kieffer, Scholer-Dahirel, Pelon, Bourachot, Cardon, Sirven, Magagna, Fuhrmann, Bernard (bib17) 2018; 33
Hanahan, Coussens (bib26) 2012; 21
Franzén, Gan, Björkegren (bib23) 2019; 2019
Wang, Wang, Peters, Ding, Ribback, Utpatel, Cigliano, Dombrowski, Xu, Chen (bib72) 2019; 71
Sahai, Astsaturov, Cukierman, DeNardo, Egeblad, Evans, Fearon, Greten, Hingorani, Hunter (bib61) 2020; 20
Reimand, Isserlin, Voisin, Kucera, Tannus-Lopes, Rostamianfar, Wadi, Meyer, Wong, Xu (bib55) 2019; 14
Elyada, Bolisetty, Laise, Flynn, Courtois, Burkhart, Teinor, Belleau, Biffi, Lucito (bib20) 2019; 9
Michalopoulos, DeFrances (bib44) 1997; 276
Ozdemir, Pentcheva-Hoang, Carstens, Zheng, Wu, Simpson, Laklai, Sugimoto, Kahlert, Novitskiy (bib48) 2014; 25
Raudvere, Kolberg, Kuzmin, Arak, Adler, Peterson, Vilo (bib53) 2019; 47
Rizvi, Fischbach, Bronk, Hirsova, Krishnan, Dhanasekaran, Smadbeck, Smoot, Vasmatzis, Gores (bib58) 2018; 9
Su, Chen, Yao, Liu, Yu, Lao, Wang, Luo, Xing, Chen (bib67) 2018; 172
Yang, Noureddin, Liu, Ohashi, Kim, Ramnath, Powell, Sweet, Roh, Hsin (bib73) 2019; 11
Algul, Treiber, Lesina, Nakhai, Saur, Geisler, Pfeifer, Paxian, Schmid (bib2) 2007; 117
Phaneuf, Moscioni, LeClair, Raper, Wilson (bib49) 2004; 23
McInnes, Healy (bib40) 2018
Ma, Hernandez, Zhao, Mehta, Tran, Kelly, Rae, Hernandez, Davis, Martin (bib36) 2019; 36
34129825 - Cancer Cell. 2021 Jun 14;39(6):883
References_xml – volume: 5
  start-page: e129212
  year: 2019
  ident: bib27
  article-title: Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
  publication-title: JCI Insight
– volume: 25
  start-page: 719
  year: 2014
  end-page: 734
  ident: bib48
  article-title: Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival
  publication-title: Cancer Cell
– volume: 4
  start-page: 2823
  year: 2013
  ident: bib41
  article-title: Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
  publication-title: Nat. Commun.
– volume: 72
  start-page: 95
  year: 2020
  end-page: 103
  ident: bib15
  article-title: Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis
  publication-title: J. Hepatol.
– volume: 36
  start-page: 418
  year: 2019
  end-page: 430.e16
  ident: bib36
  article-title: Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer
  publication-title: Cancer Cell
– volume: 20
  start-page: 174
  year: 2020
  end-page: 186
  ident: bib61
  article-title: A framework for advancing our understanding of cancer-associated fibroblasts
  publication-title: Nat. Rev. Cancer
– volume: 122
  start-page: 2911
  year: 2012
  end-page: 2915
  ident: bib22
  article-title: Cholangiocarcinomas can originate from hepatocytes in mice
  publication-title: J. Clin. Invest.
– volume: 67
  start-page: 2414
  year: 2018
  end-page: 2429
  ident: bib12
  article-title: MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis
  publication-title: Hepatology
– volume: 101
  start-page: 147
  year: 2020
  end-page: 176
  ident: bib8
  article-title: Diversity and biology of cancer-associated fibroblasts
  publication-title: Physiol. Rev.
– volume: 6
  start-page: 48
  year: 2018
  ident: bib39
  article-title: Hyaluronan, cancer-associated fibroblasts and the tumor microenvironment in malignant progression
  publication-title: Front. Cell Dev. Biol.
– volume: 18
  start-page: 99
  year: 2019
  end-page: 115
  ident: bib13
  article-title: Turning foes to friends: targeting cancer-associated fibroblasts
  publication-title: Nat. Rev. Drug Discov.
– volume: 139
  start-page: 891
  year: 2009
  end-page: 906
  ident: bib33
  article-title: Matrix crosslinking forces tumor progression by enhancing integrin signaling
  publication-title: Cell
– volume: 73
  start-page: 897
  year: 2013
  end-page: 907
  ident: bib43
  article-title: Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma
  publication-title: Cancer Res.
– volume: 46
  start-page: 1
  year: 1986
  end-page: 7
  ident: bib34
  article-title: Tumor invasion and metastases—role of the extracellular matrix: Rhoads Memorial Award lecture
  publication-title: Cancer Res.
– volume: 41
  start-page: 1558
  year: 2010
  end-page: 1565
  ident: bib57
  article-title: Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract
  publication-title: Hum. Pathol.
– volume: 21
  start-page: 418
  year: 2012
  end-page: 429
  ident: bib51
  article-title: Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma
  publication-title: Cancer Cell
– volume: 172
  start-page: 841
  year: 2018
  end-page: 856.e16
  ident: bib67
  article-title: CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness
  publication-title: Cell
– volume: 499
  start-page: 346
  year: 2013
  end-page: 349
  ident: bib68
  article-title: High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat
  publication-title: Nature
– volume: 17
  start-page: 75
  year: 2016
  ident: bib35
  article-title: Pooling across cells to normalize single-cell RNA sequencing data with many zero counts
  publication-title: Genome Biol.
– volume: 37
  start-page: 1062
  year: 2019
  end-page: 1069
  ident: bib52
  article-title: Phase IB/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: swog S1313
  publication-title: J. Clin. Oncol.
– volume: 25
  start-page: 1057
  year: 2019
  end-page: 1063
  ident: bib14
  article-title: Programmable bacteria induce durable tumor regression and systemic antitumor immunity
  publication-title: Nat. Med.
– volume: 20
  start-page: 53
  year: 1987
  end-page: 65
  ident: bib60
  article-title: Silhouettes: a graphical aid to the interpretation and validation of cluster analysis
  publication-title: J. Comput. Appl. Math.
– volume: 4
  start-page: 528
  year: 2004
  end-page: 539
  ident: bib69
  article-title: Hyaluronan: from extracellular glue to pericellular cue
  publication-title: Nat. Rev. Cancer
– volume: 214
  start-page: 579
  year: 2017
  end-page: 596
  ident: bib47
  article-title: Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
  publication-title: J. Exp. Med.
– volume: 71
  start-page: 742
  year: 2019
  end-page: 752
  ident: bib72
  article-title: Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis
  publication-title: J. Hepatol.
– volume: 101
  start-page: 4477
  year: 2004
  end-page: 4482
  ident: bib28
  article-title: Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair
  publication-title: Proc. Natl. Acad. Sci. U S A
– volume: 18
  start-page: 341
  year: 2018
  end-page: 358
  ident: bib16
  article-title: Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
  publication-title: Nat. Rev. Cancer
– volume: 144
  start-page: 829
  year: 2013
  end-page: 840
  ident: bib64
  article-title: Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes
  publication-title: Gastroenterology
– volume: 92
  start-page: 387
  year: 2017
  end-page: 455
  ident: bib63
  article-title: The stellate cell system (vitamin A-storing cell system)
  publication-title: Anat. Sci. Int.
– volume: 56
  start-page: 71
  year: 2019
  end-page: 79
  ident: bib6
  article-title: Cancer associated fibroblasts: is the force the path to the dark side?
  publication-title: Curr. Opin. Cell Biol.
– volume: 62
  start-page: 1497
  year: 2015
  end-page: 1510
  ident: bib37
  article-title: YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
  publication-title: Hepatology
– volume: 9
  start-page: 5892
  year: 2018
  end-page: 5905
  ident: bib58
  article-title: YAP-associated chromosomal instability and cholangiocarcinoma in mice
  publication-title: Oncotarget
– volume: 38
  start-page: 500
  year: 2006
  end-page: 501
  ident: bib54
  article-title: GenePattern 2.0
  publication-title: Nat. Genet.
– volume: 22
  start-page: 697
  year: 2010
  end-page: 706
  ident: bib19
  article-title: Dynamic interplay between the collagen scaffold and tumor evolution
  publication-title: Curr. Opin. Cell Biol.
– volume: 136
  start-page: 2825
  year: 2009
  end-page: 2835
  ident: bib38
  article-title: Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb
  publication-title: Development
– volume: 21
  start-page: 309
  year: 2012
  end-page: 322
  ident: bib26
  article-title: Accessories to the crime: functions of cells recruited to the tumor microenvironment
  publication-title: Cancer Cell
– volume: 562
  start-page: 69
  year: 2018
  end-page: 75
  ident: bib62
  article-title: Necroptosis microenvironment directs lineage commitment in liver cancer
  publication-title: Nature
– volume: 2019
  year: 2019
  ident: bib23
  article-title: PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data
  publication-title: Database
– volume: 12
  start-page: 153
  year: 2017
  end-page: 186
  ident: bib1
  article-title: The role of cancer-associated fibroblasts and fibrosis in liver cancer
  publication-title: Annu. Rev. Pathol.
– volume: 88
  start-page: 125
  year: 2008
  end-page: 172
  ident: bib24
  article-title: Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver
  publication-title: Physiol. Rev.
– volume: 33
  start-page: 463
  year: 2018
  end-page: 479.e10
  ident: bib17
  article-title: Fibroblast heterogeneity and immunosuppressive environment in human breast cancer
  publication-title: Cancer Cell
– volume: 7
  start-page: 1224
  year: 2017
  end-page: 1237
  ident: bib46
  article-title: Tissue force programs cell fate and tumor aggression
  publication-title: Cancer Discov.
– volume: 17
  start-page: 557
  year: 2020
  end-page: 588
  ident: bib4
  article-title: Cholangiocarcinoma 2020: the next horizon in mechanisms and management
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
– volume: 9
  start-page: 1102
  year: 2019
  end-page: 1123
  ident: bib20
  article-title: Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts
  publication-title: Cancer Discov.
– volume: 150
  start-page: 720
  year: 2016
  end-page: 733
  ident: bib45
  article-title: Epithelial transforming growth factor-beta signaling does not contribute to liver fibrosis but protects mice from cholangiocarcinoma
  publication-title: Gastroenterology
– volume: 25
  start-page: 735
  year: 2014
  end-page: 747
  ident: bib56
  article-title: Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma
  publication-title: Cancer Cell
– volume: 1
  start-page: 100035
  year: 2020
  ident: bib3
  article-title: A random matrix theory approach to Denoise single-cell data
  publication-title: Patterns (N Y)
– volume: 23
  start-page: 592
  year: 2004
  end-page: 603
  ident: bib49
  article-title: Generation of a mouse expressing a conditional knockout of the hepatocyte growth factor gene: demonstration of impaired liver regeneration
  publication-title: DNA Cell Biol.
– volume: 58
  start-page: 1461
  year: 2013
  end-page: 1473
  ident: bib50
  article-title: Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice
  publication-title: Hepatology
– volume: 117
  start-page: 1490
  year: 2007
  end-page: 1501
  ident: bib2
  article-title: Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis
  publication-title: J. Clin. Invest.
– volume: 17
  start-page: 135
  year: 2010
  end-page: 147
  ident: bib21
  article-title: Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner
  publication-title: Cancer Cell
– volume: 6
  start-page: 10008
  year: 2008
  ident: bib9
  article-title: Fast unfolding of communities in large networks
  publication-title: J. Stat. Mech. Theor. Exp
– volume: 9
  start-page: 44
  year: 2011
  end-page: 54
  ident: bib65
  article-title: The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
– volume: 7
  start-page: 16878
  year: 2017
  ident: bib5
  article-title: QuPath: open source software for digital pathology image analysis
  publication-title: Sci. Rep.
– volume: 11
  start-page: eaat9284
  year: 2019
  ident: bib73
  article-title: Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis
  publication-title: Sci. Transl. Med.
– volume: 2015
  start-page: 563818
  year: 2015
  ident: bib18
  article-title: Size matters: molecular weight specificity of hyaluronan effects in cell biology
  publication-title: Int. J. Cell Biol.
– volume: 563
  start-page: 347
  year: 2018
  end-page: 353
  ident: bib70
  article-title: Single-cell reconstruction of the early maternal-fetal interface in humans
  publication-title: Nature
– volume: 4
  start-page: 844
  year: 1998
  end-page: 847
  ident: bib31
  article-title: Tissue microarrays for high-throughput molecular profiling of tumor specimens
  publication-title: Nat. Med.
– volume: 462
  start-page: 108
  year: 2009
  end-page: 112
  ident: bib7
  article-title: Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
  publication-title: Nature
– volume: 47
  start-page: W191
  year: 2019
  end-page: W198
  ident: bib53
  article-title: g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
  publication-title: Nucleic Acids Res.
– volume: 37
  start-page: 3229
  year: 2018
  end-page: 3242
  ident: bib71
  article-title: Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice
  publication-title: Oncogene
– volume: 1
  start-page: 692
  year: 2020
  end-page: 708
  ident: bib25
  article-title: Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome
  publication-title: Nat. Cancer
– volume: 16
  start-page: 582
  year: 2016
  end-page: 598
  ident: bib30
  article-title: The biology and function of fibroblasts in cancer
  publication-title: Nat. Rev. Cancer
– volume: 17
  start-page: 29
  year: 2016
  ident: bib29
  article-title: Classification of low quality cells from single-cell RNA-seq data
  publication-title: Genome Biol.
– volume: 14
  start-page: 482
  year: 2019
  end-page: 517
  ident: bib55
  article-title: Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap
  publication-title: Nat. Protoc.
– volume: 177
  start-page: 1888
  year: 2019
  end-page: 1902.e21
  ident: bib66
  article-title: Comprehensive integration of single-cell data
  publication-title: Cell
– volume: 10
  start-page: 305
  year: 2015
  end-page: 315
  ident: bib42
  article-title: High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers
  publication-title: Nat. Protoc.
– year: 2018
  ident: bib40
  article-title: UMAP: uniform manifold approximation and projection for dimension reduction
  publication-title: arXiv
– volume: 276
  start-page: 60
  year: 1997
  end-page: 66
  ident: bib44
  article-title: Liver regeneration
  publication-title: Science
– volume: 29
  start-page: 1859
  year: 2018
  end-page: 1873
  ident: bib10
  article-title: Cellular origin and functional relevance of collagen I production in the kidney
  publication-title: J. Am. Soc. Nephrol.
– volume: 8
  start-page: 151
  year: 1999
  end-page: 163
  ident: bib32
  article-title: Far upstream regulatory elements enhance position-independent and uterus-specific expression of the murine alpha1(I) collagen promoter in transgenic mice
  publication-title: Gene Expr.
– volume: 15
  start-page: 95
  year: 2018
  end-page: 111
  ident: bib59
  article-title: Cholangiocarcinoma - evolving concepts and therapeutic strategies
  publication-title: Nat. Rev. Clin. Oncol.
– volume: 73
  start-page: 1118
  year: 2020
  end-page: 1130
  ident: bib74
  article-title: Single cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
  publication-title: J. Hepatol.
– volume: 33
  start-page: 4284
  year: 2015
  end-page: 4292
  ident: bib11
  article-title: Randomized phase ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer
  publication-title: J. Clin. Oncol.
– reference: 34129825 - Cancer Cell. 2021 Jun 14;39(6):883
SSID ssj0016179
Score 2.6913657
Snippet Cancer-associated fibroblasts (CAF) are a poorly characterized cell population in the context of liver cancer. Our study investigates CAF functions in...
SourceID pubmedcentral
proquest
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 866
SubjectTerms Aged
Animals
Bile Duct Neoplasms - genetics
Bile Duct Neoplasms - metabolism
Bile Duct Neoplasms - pathology
Bile Ducts, Intrahepatic - pathology
Cancer-Associated Fibroblasts - metabolism
Cancer-Associated Fibroblasts - pathology
CellPhoneDB
cholangiocarcinoma
Cholangiocarcinoma - genetics
Cholangiocarcinoma - metabolism
Cholangiocarcinoma - pathology
Collagen Type I - metabolism
Female
Hepatic Stellate Cells - cytology
Hepatic Stellate Cells - pathology
Hepatocyte Growth Factor - metabolism
HGF
Humans
Hyaluronan Synthases - genetics
Hyaluronan Synthases - metabolism
Hyaluronic Acid - metabolism
immune
KRAS
Male
mechanosensitive
Mice, Transgenic
Middle Aged
Proto-Oncogene Proteins c-met - metabolism
single cell
stiffness
Tumor Microenvironment
YAP
Title Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
URI https://dx.doi.org/10.1016/j.ccell.2021.03.012
https://www.ncbi.nlm.nih.gov/pubmed/33930309
https://www.proquest.com/docview/2520863919
https://pubmed.ncbi.nlm.nih.gov/PMC8241235
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS-wwEA_iQbyIX--5fhHBa9ht0o_kqKKIoAgq7EVC0iS6D2yX3e7B_96ZtF1c381jmxzCzHTmN53fTAg5D6XzEIULZjNZslTylEnjDPMOO9EdL0LAiu79Q377kt6Ns_Eauep7YZBW2fn-1qdHb929GXbSHE4nk-ETfKsY_CVP4hAY7CgXqYxNfOPLZSUBIrRqZ6ZmDHf3k4cix6vEv-OQJPIkTjrFaym_haT_IedP5uS3UHSzTbY6DEkv2mPukDVf7ZKN-65KvkdeH1uOXV3ROtCYvVZvEwhaM1ivPwx9g9y7eaf2k7pIy_C0ROXPmOmU5R0NkEfXFrB1Q-cLO13e8zXfJ883189Xt6y7RoGBFpKGOcjAAFiVRkphbZ57Jw1XLjelGymsfJpkZAslPech996nhbUmLVWwUtrgxB-yXtWVPyA080EJA5gtL2JF1IrUGicAUVkLMEMOSN5LT68oUYN_1j2f7J-OYtcodj0SGsQ-IGe9rDWYNy6byteLueYZh6RLqEQNyN9W9nrazuHQQiiBFaIBKVa0styAo7NXV6rJexyhDTaJTcKHvz3wEdnEJ-SMJekxWW9mC38C6KSxp9H8vgD_ROeA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa6Dth6KfZu9tSAXY3Ekh_SsStWpFtTDFgG5DIIkiW1GVA7SJxD__1I2Q6a7barqYPwUSI_mhQJ8ClUzqMXLhObyyrJJM8SaZxJvKOX6I6XIVBGd3ZVTH9mXxf54gDOhrcwVFbZ2_7Opkdr3X8Z92iOV8vl-AfeVXL-kqexCUz5AB4iGyhpfsPF4vMulYAuWnVNU_OElg-th2KRV0W_xzFK5GlsdUpzKe_5pH8559-lk_d80fkTOO5JJDvt9vkUDnz9DB7N-jT5c_j1vSuya2rWBBbD1_p6iV5rjfLm1rBrDL7bG2bvmIt1GZ5VpP11YnpteccCBtKNRXLdss3WrnaDvjYvYH7-ZX42Tfo5CgmqIW0ThyEYMqvKSCmsLQrvpOHKFaZyE0WpT5NObKmk5zwU3vustNZklQpWShuceAmHdVP7E2C5D0oYJG0IM6VErciscQIplbXIM-QIigE9vadFjQZaDwVlv3WEXRPseiI0wj6CjwPWGs83iU3tm-1G85xj1CVUqkbwqsNer7pGHFoIJShFNIJyTyu7BdQ7e19SL29iD208lPRK-PX_bvgDPJ7OZ5f68uLq2xs4IgkVkKXZWzhs11v_DqlKa9_Ho_gHp4Lqnw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Promotion+of+cholangiocarcinoma+growth+by+diverse+cancer-associated+fibroblast+subpopulations&rft.jtitle=Cancer+cell&rft.au=Affo%2C+Silvia&rft.au=Nair%2C+Ajay&rft.au=Brundu%2C+Francesco&rft.au=Ravichandra%2C+Aashreya&rft.date=2021-06-14&rft.pub=Elsevier+Inc&rft.issn=1535-6108&rft.eissn=1878-3686&rft.volume=39&rft.issue=6&rft.spage=866&rft.epage=882.e11&rft_id=info:doi/10.1016%2Fj.ccell.2021.03.012&rft.externalDocID=S1535610821001707
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1535-6108&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1535-6108&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1535-6108&client=summon